Literature DB >> 31147933

In Vitro Studies of MHC Class I Peptide Loading and Exchange.

Marlene Bouvier1.   

Abstract

In the endoplasmic reticulum (ER), MHC class I molecules associate with several specialized proteins, forming a large macromolecular complex referred to as the "peptide-loading complex" (PLC). In the PLC, antigenic peptides undergo a stringent selection process that determines which antigen becomes part of the repertoire presented by MHC class I molecules. This ensures that the immune system elicits robust CD8+ T-cell responses to viruses and solid tumors. The ability to reconstitute in vitro MHC class I molecules in association with key proteins of the PLC provides a mean for studying at the molecular level how antigenic peptides are selected for presentation to CD8+ T-cells. Here, we describe practical procedures for generating a cell-free system made up of MHC class I molecules and tapasin that can be used for mechanistic studies of peptide loading and exchange.

Entities:  

Keywords:  Fluorescence anisotropy; MHC class I molecule; Peptide association; Peptide dissociation; Peptide exchange; Peptide-loading complex; Tapasin

Mesh:

Substances:

Year:  2019        PMID: 31147933      PMCID: PMC7278038          DOI: 10.1007/978-1-4939-9450-2_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  15 in total

1.  Stabilization of soluble, low-affinity HLA-DM/HLA-DR1 complexes by leucine zippers.

Authors:  Robert Busch; Achal Pashine; K Christopher Garcia; Elizabeth D Mellins
Journal:  J Immunol Methods       Date:  2002-05-01       Impact factor: 2.303

2.  A characterization of the lumenal region of human tapasin reveals the presence of two structural domains.

Authors:  Mingnan Chen; Walter F Stafford; Gundo Diedrich; Amir Khan; Marlene Bouvier
Journal:  Biochemistry       Date:  2002-12-10       Impact factor: 3.162

3.  Structural characterization of a soluble and partially folded class I major histocompatibility heavy chain/beta 2m heterodimer.

Authors:  M Bouvier; D C Wiley
Journal:  Nat Struct Biol       Date:  1998-05

4.  Spectroscopic determination of tryptophan and tyrosine in proteins.

Authors:  H Edelhoch
Journal:  Biochemistry       Date:  1967-07       Impact factor: 3.162

5.  Fast association rates suggest a conformational change in the MHC class I molecule H-2Db upon peptide binding.

Authors:  S Springer; K Doring; J C Skipper; A R Townsend; V Cerundolo
Journal:  Biochemistry       Date:  1998-03-03       Impact factor: 3.162

6.  Expression of recombinant HLA-DR2 molecules. Replacement of the hydrophobic transmembrane region by a leucine zipper dimerization motif allows the assembly and secretion of soluble DR alpha beta heterodimers.

Authors:  A Kalandadze; M Galleno; L Foncerrada; J L Strominger; K W Wucherpfennig
Journal:  J Biol Chem       Date:  1996-08-16       Impact factor: 5.157

7.  ERAP1-ERAP2 dimerization increases peptide-trimming efficiency.

Authors:  Irini Evnouchidou; Mirjana Weimershaus; Loredana Saveanu; Peter van Endert
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

8.  HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides.

Authors:  D N Garboczi; D T Hung; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

9.  Analysis of interactions in a tapasin/class I complex provides a mechanism for peptide selection.

Authors:  Mingnan Chen; Marlene Bouvier
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

10.  Role of chain pairing for the production of functional soluble IA major histocompatibility complex class II molecules.

Authors:  C A Scott; K C Garcia; F R Carbone; I A Wilson; L Teyton
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

View more
  1 in total

1.  Assessment of SARS-CoV-2 specific CD4(+) and CD8 (+) T cell responses using MHC class I and II tetramers.

Authors:  Yuri Poluektov; Marybeth George; Pirouz Daftarian; Marc C Delcommenne
Journal:  Vaccine       Date:  2021-03-05       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.